Trump administration reveals ‘most favored nation’ drug price country targetsnews2025-05-20T14:21:32+00:00May 20th, 2025|Endpoints News|
HHS can require approval for drugmakers to apply 340B rebate models, court rulesnews2025-05-16T19:38:00+00:00May 16th, 2025|Endpoints News|
Amarin urges Supreme Court to decline Hikma’s drug label spatnews2025-05-16T16:51:33+00:00May 16th, 2025|Endpoints News|
Regeneron gets $400M+ jury win in Amgen cholesterol drug casenews2025-05-15T21:16:54+00:00May 15th, 2025|Endpoints News|
CRISPR patent spat revived by federal appeals court rulingnews2025-05-13T20:05:09+00:00May 13th, 2025|Endpoints News|
HHS issues guidance for third round of drug price negotiationsnews2025-05-13T16:44:06+00:00May 13th, 2025|Endpoints News|
Trump’s drug price plan is light on details, may have little impactnews2025-05-12T19:31:11+00:00May 12th, 2025|Endpoints News|
Republican tax cut bill includes PBM, drug price negotiation changesnews2025-05-12T17:18:52+00:00May 12th, 2025|Endpoints News|
AstraZeneca loses appeals court fight over IRA drug price negotiationsnews2025-05-08T18:18:36+00:00May 8th, 2025|Endpoints News|
Avadel can seek to expand Lumryz’s label after court rulingnews2025-05-07T16:58:56+00:00May 7th, 2025|Endpoints News|
